Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan - Wikidata - wikimedia - TriplyDB

Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan

Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan

http://www.wikidata.org/entity/Q36725461

about

Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities.Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.Evidence for a dysregulated immune system in the etiology of psychiatric disorders.Inflammatory cytokine network in schizophrenia.Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment.Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia.Levels of interleukin-6 and high-sensitivity C-reactive protein reflecting mania severity in bipolar disorder.A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.Minocycline as adjunct therapy for a male patient with deficit schizophrenia Neuroinflammation in Schizophrenia: A Critical Review and The Future Human Endogenous Retroviral Envelope Protein Syncytin-1 and Inflammatory Abnormalities in Neuropsychological Diseases

P2860

Q36625412-6B226BDB-AB30-434C-8256-3C2C6AFDC6A8 Q36907446-0DE53791-DDEE-4261-8571-FD3583EFC9F3 Q38104284-F1FBA2A6-0C12-44A1-8642-F7FFAD6A9F57 Q38138169-A339065A-35CA-4AC6-86CA-93EE2261E456 Q44336042-61E5C9EE-FCA6-42E2-9771-1AD98E0593D5 Q47194564-14C3EB74-29CC-4C76-BB8A-A0F49D7F1F55 Q47264832-40EC4A12-02D9-4BC6-B14E-3F3AB79CFFAE Q48063321-8E985D87-C2F1-46F8-9606-063A518C1CF5 Q48507006-D5F09734-01AF-48DE-81F5-93F2574367EC Q57815583-F54C9204-EE77-4A25-B692-A6AB1708C4AE Q57820155-907B0EA9-68DF-497D-A44C-C2324AC90356 Q58758788-C7E3121F-F441-42ED-BAA3-8F73C134CE9D

P2860

Inflammation in patients with schizophrenia: the therapeutic benefits of risperidone plus add-on dextromethorphan

http://www.wikidata.org/entity/Q36725461

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Inflammation in patients with ...... e plus add-on dextromethorphan

@ast

Inflammation in patients with ...... e plus add-on dextromethorphan

@en

type

label

Inflammation in patients with ...... e plus add-on dextromethorphan

@ast

Inflammation in patients with ...... e plus add-on dextromethorphan

@en

prefLabel

Inflammation in patients with ...... e plus add-on dextromethorphan

@ast

Inflammation in patients with ...... e plus add-on dextromethorphan

@en

P1433

Q36725461-5BC63C6E-CC8E-4E79-BAD7-D34418924855

P1476

Q36725461-A427A0B1-6B89-49B1-BFD0-1AB61C472E8B

P2093

Q36725461-0C073332-1C7F-486C-8B27-2E148F821703

Q36725461-1CBBD3C0-2A86-4C0B-8FFE-6036383F21A5

Q36725461-41587880-6489-4DE8-A4FC-A683E245DF2B

Q36725461-4EFAEE34-13C2-446E-BC52-99FE285B7CF4

Q36725461-4FDB6B0D-4782-42B8-B37A-A1E789FA606D

Q36725461-603CFF2B-4353-48B3-B73A-70719BB34106

Q36725461-77E391F1-7DA2-4707-97F5-3061E5EE4FA0

Q36725461-AF8AFCC2-6EB9-4CE2-B9CA-E29A37229D72

Q36725461-B309F2AB-803B-4570-B2DF-ABA273CBE014

Q36725461-D538F398-EB27-4745-A6DD-44C54F6875A8

P2860

Q36725461-010A70CE-070C-497E-8236-C526B31BBA08

Q36725461-0707C1C5-E778-491D-8016-99BBD18891B6

Q36725461-09C47508-B458-4701-A98A-F8842651D8FB

Q36725461-0E839F09-B528-4B8B-8BC4-593AA452FB97

Q36725461-10AC2577-81BD-46DF-B1FB-D4AF3268A11F

Q36725461-1428B11A-F1D5-4EC2-A75E-BF1FC5AC92A5

Q36725461-1AE99987-ABD3-4646-B0B9-05AEB2D5408A

Q36725461-1BEF3F0E-6473-457D-927C-F9456856542B

Q36725461-21151F8F-661E-4F99-9A26-614FA42143BF

Q36725461-24DFA24D-0AE8-44A6-90FE-4EA419D37788

P2888

Q36725461-2C7490D2-D97A-4963-AF85-FB2841A79EAC

P304

Q36725461-16A9AE9D-E438-4E12-94E4-29301CA1711A

P31

Q36725461-E60F74CB-87D5-4499-BA97-92499649EBEB

P356

Q36725461-06EEB02D-D18B-4474-946A-0E1FF4417C24

P433

Q36725461-FED4F7FE-DB0C-4979-86BA-272A6DE2944D

P478

Q36725461-1407FFBA-F35F-489A-8C33-C48EC1B7C419

P577

Q36725461-B7C9C6AD-C00D-4AED-A145-E38EDB50FD63

P5875

Q36725461-80691CC9-F167-457A-A579-730E41325097

P698

Q36725461-4B7AE0E1-4BC4-4F00-BB00-B09FE72FF763

P921

Q36725461-E8BC5E76-6866-4151-848C-98F83DC5E5BB

P932

Q36725461-90E93F2A-B6FB-40D9-94C3-12C8DCC02709

P356

S11481-012-9382-Z

P1433

Journal of Neuroimmune Pharmacology

P1476

Inflammation in patients with ...... e plus add-on dextromethorphan

@en

P2093

Chun-Hsieh Chu

http://www.w3.org/2001/XMLSchema#string

I-Hui Lee

http://www.w3.org/2001/XMLSchema#string

Jau-Shyong Hong

http://www.w3.org/2001/XMLSchema#string

Nian-Sheng Tzeng

http://www.w3.org/2001/XMLSchema#string

Po-See Chen

http://www.w3.org/2001/XMLSchema#string

Ru-Band Lu

http://www.w3.org/2001/XMLSchema#string

San-Yuan Huang

http://www.w3.org/2001/XMLSchema#string

Sheng-Yu Lee

http://www.w3.org/2001/XMLSchema#string

Shih-Heng Chen

http://www.w3.org/2001/XMLSchema#string

Shiou-Lan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

The positive and negative syndrome scale (PANSS) for schizophrenia

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia.

A new aspect of the TrkB signaling pathway in neural plasticity.

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment

Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP.

Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia.

Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder.

P2888

s11481-012-9382-z

P304

656-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11481-012-9382-Z

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228063957

http://www.w3.org/2001/XMLSchema#string

P698

22730040

http://www.w3.org/2001/XMLSchema#string

P921

P932

3611097

http://www.w3.org/2001/XMLSchema#string